For example, Petirdis et al. studied 655 British women under the age of 40 with pure DCIS and observed that the BRCA2 mutations were more common than the pathogenic BRCA1 variants (3.5% vs. 0.6%) [18]. The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.